| scholarly article | Q13442814 |
| P356 | DOI | 10.3389/FNANA.2014.00042 |
| P8608 | Fatcat ID | release_a5kitmmme5gb7cza2eilfjjkli |
| P932 | PMC publication ID | 4051274 |
| P698 | PubMed publication ID | 24959122 |
| P5875 | ResearchGate publication ID | 263432585 |
| P50 | author | Lucy Vulchanova | Q55708881 |
| R Scott McIvor | Q114401924 | ||
| Lalitha R Belur | Q114401927 | ||
| P2093 | author name string | Carolyn A Fairbanks | |
| Maureen S Riedl | |||
| Daniel J Schuster | |||
| Kelley F Kitto | |||
| Robert P Elde | |||
| Jaclyn A Dykstra | |||
| P2860 | cites work | Microglia-specific localisation of a novel calcium binding protein, Iba1 | Q28273977 |
| Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses | Q30531601 | ||
| Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy | Q30541880 | ||
| Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons | Q33822237 | ||
| Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture | Q33975660 | ||
| Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice. | Q34321271 | ||
| Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome | Q34365749 | ||
| Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection | Q34770058 | ||
| Terminal N-linked galactose is the primary receptor for adeno-associated virus 9. | Q34787342 | ||
| Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain | Q35000819 | ||
| The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice | Q35015807 | ||
| Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates | Q35086714 | ||
| Spinal delivery of analgesics in experimental models of pain and analgesia | Q35205465 | ||
| Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I. | Q35559945 | ||
| Genetic tracing of Nav1.8-expressing vagal afferents in the mouse | Q35837465 | ||
| Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates | Q35892068 | ||
| Glycan binding avidity determines the systemic fate of adeno-associated virus type 9. | Q36276561 | ||
| Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain | Q36458975 | ||
| Intravenous delivery of adeno-associated viral vector serotype 9 mediates effective gene expression in ischemic stroke lesion and brain angiogenic foci | Q36493030 | ||
| Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates | Q36745664 | ||
| Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates | Q36848703 | ||
| Multiplicity of cerebrospinal fluid functions: New challenges in health and disease | Q37163564 | ||
| Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery | Q37355740 | ||
| Intrathecal AAV serotype 9-mediated delivery of shRNA against TRPV1 attenuates thermal hyperalgesia in a mouse model of peripheral nerve injury | Q37562075 | ||
| AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction | Q37571781 | ||
| Sustained correction of motoneuron histopathology following intramuscular delivery of AAV in pompe mice. | Q37696025 | ||
| The advent of AAV9 expands applications for brain and spinal cord gene delivery | Q38004089 | ||
| Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transfer | Q39566137 | ||
| Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals. | Q41080089 | ||
| A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage | Q41183035 | ||
| Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery | Q42059455 | ||
| Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn | Q42177229 | ||
| Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord | Q42257686 | ||
| Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons | Q42263324 | ||
| Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes | Q42739394 | ||
| Visualization of spinal afferent innervation in the mouse colon by AAV8-mediated GFP expression. | Q42925040 | ||
| AAV8(gfp) preferentially targets large diameter dorsal root ganglion neurones after both intra-dorsal root ganglion and intrathecal injection | Q44655971 | ||
| Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain | Q44686125 | ||
| Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. | Q44899252 | ||
| Transgene expression and effective gene silencing in vagal afferent neuronsin vivousing recombinant adeno-associated virus vectors | Q45373500 | ||
| Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery | Q45868795 | ||
| Intrathecal shRNA-AAV9 inhibits target protein expression in the spinal cord and dorsal root ganglia of adult mice | Q45879078 | ||
| Clearance of albumin from mouse subarachnoid space: a measure of CSF bulk flow | Q70520829 | ||
| Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice | Q72640892 | ||
| P921 | main subject | vector-borne disease | Q2083837 |
| P304 | page(s) | 42 | |
| P577 | publication date | 2014-06-10 | |
| P1433 | published in | Frontiers in Neuroanatomy | Q1893158 |
| P1476 | title | Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse | |
| P478 | volume | 8 |
| Q64287660 | A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice |
| Q91781812 | A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna |
| Q36352399 | A Single Injection of Recombinant Adeno-Associated Virus into the Lumbar Cistern Delivers Transgene Expression Throughout the Whole Spinal Cord. |
| Q57165754 | A bright future? Optogenetics in the periphery for pain research and therapy |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q100430604 | AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease |
| Q36588788 | AAV9-mediated central nervous system-targeted gene delivery via cisterna magna route in mice |
| Q38826941 | Adeno-Associated Viral Vector Delivery to the Enteric Nervous System: A Review |
| Q92069614 | Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation |
| Q38703339 | Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration |
| Q54944159 | Adeno-associated virus 2/9 delivery of Cre recombinase in mouse primary afferents. |
| Q47102617 | Adeno-associated virus serotype rh10 is a useful gene transfer vector for sensory nerves that innervate bone in immunodeficient mice. |
| Q49874005 | Advances in spinal muscular atrophy therapeutics |
| Q90305369 | Allele-specific RNA interference prevents neuropathy in Charcot-Marie-Tooth disease type 2D mouse models |
| Q55339450 | Autism spectrum disorder: prospects for treatment using gene therapy. |
| Q59354904 | Cerebrospinal Fluid-Directed rAAV9-rsATP7A Plus Subcutaneous Copper Histidinate Advance Survival and Outcomes in a Menkes Disease Mouse Model |
| Q36543422 | Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease |
| Q35658521 | Current gene therapy using viral vectors for chronic pain |
| Q38761724 | Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery |
| Q40235080 | Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders |
| Q27318087 | Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII. |
| Q90205161 | Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice |
| Q38941931 | Gene Therapeutic Reversal of Peripheral Olfactory Impairment in Bardet-Biedl Syndrome. |
| Q92089380 | Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease |
| Q94503876 | Gene Transfer in Rodent Nervous Tissue Following Hindlimb Intramuscular Delivery of Recombinant Adeno-Associated Virus Serotypes AAV2/6, AAV2/8, and AAV2/9 |
| Q47558790 | Gene therapy for Mucopolysaccharidoses. |
| Q45872420 | Gene therapy with the TRF1 telomere gene rescues decreased TRF1 levels with aging and prolongs mouse health span |
| Q40611143 | Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies |
| Q40228879 | Improved gene delivery to adult mouse spinal cord through the use of engineered hybrid adeno-associated viral serotypes. |
| Q94476154 | Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases? |
| Q34341997 | Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice |
| Q95935116 | Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10 |
| Q41921977 | In Vivo Selection of a Computationally Designed SCHEMA AAV Library Yields a Novel Variant for Infection of Adult Neural Stem Cells in the SVZ. |
| Q92615014 | MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients |
| Q89879783 | Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases |
| Q43113417 | Neuroanatomy and transgenic technologies. |
| Q64082902 | On the development of optical peripheral nerve interfaces |
| Q92522172 | Optogenetic recruitment of spinal reflex pathways from large-diameter primary afferents in non-transgenic rats transduced with AAV9/Channelrhodopsin 2 |
| Q59137624 | Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion |
| Q92487813 | Progress and challenges of gene therapy for Pompe disease |
| Q41126219 | Proof-of-concept: neonatal intravenous injection of adeno-associated virus vectors results in successful transduction of myenteric and submucosal neurons in the mouse small and large intestine |
| Q54245962 | Slow Infusion of Recombinant Adeno-Associated Viruses into the Mouse Cerebrospinal Fluid Space. |
| Q38811165 | Stacking up CRISPR against RNAi for therapeutic gene inhibition |
| Q37351327 | Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model. |
| Q26767363 | Targeted approaches to induce immune tolerance for Pompe disease therapy |
| Q38963728 | Targeting the gastrointestinal tract with viral vectors: state of the art and possible applications in research and therapy |
| Q38737932 | Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology |
| Q38746238 | Viral vectors for therapy of neurologic diseases |